Getting the numbers right: statistical mischief and racial profiling in heart failure research.

Abstract

The claim that blacks die from heart failure at a rate twice that of whites is informing efforts to develop and market the drug BiDil, which is currently undergoing clinical trials to be approved by the FDA as the first drug ever specified to treat African Americans--and only African Americans--for heart failure. The drug and its companion statistic have… (More)

Topics

  • Presentations referencing similar topics